Very Long-Term Treatment with a Lactobacillus Probiotic Preparation, Lactobacillus Casei Strain Shirota, Suppresses Weight Loss in the Elderly

被引:3
|
作者
Ishikawa, Hideki [1 ,2 ]
Mutoh, Michihiro [1 ,3 ]
Yoshimura, Kenichi [4 ]
Fujii, Gen [5 ]
Nakamura, Tomiyo [6 ]
Takeshita, Tatsuya [7 ]
Wakabayashi, Keiji [8 ]
Sakai, Toshiyuki [9 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Mol Targeting Prevent, Kyoto 6020841, Japan
[2] Ishikawa Gastroenterol Clin, Osaka 5410042, Japan
[3] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 1040045, Japan
[4] Hiroshima Univ Hosp, Ctr Integrated Med Res, Hiroshima 7348551, Japan
[5] Natl Canc Ctr, Cent Radioisotope Div, Res Inst, Tokyo 1040045, Japan
[6] Ryukoku Univ, Dept Food Sci & Human Nutr, Otsu, Shiga 5202194, Japan
[7] Wakayama Med Univ, Dept Publ Hlth, Sch Med, Wakayama 6418509, Japan
[8] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan
[9] Kyoto Prefectural Univ Med, Dept Drug Discovery Med, Kyoto 6028566, Japan
关键词
BLP; Lactobacillus; long-term treatment; weight loss; DOUBLE-BLIND; RECURRENCE; PREVENTION;
D O I
10.3390/nu12061599
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Weight loss, often observed in the elderly, is associated with increased risks of various diseases. No large and long-term human study has been conducted to demonstrate the health maintenance-related effects of lactic acid bacteria preparations. To reveal the potential benefit of long-term lactic acid, the effects of bacteria-based probiotics for health maintenance were examined. This observational study included the participants from a previous clinical study designed to evaluate the effects of wheat bran biscuits orLactobacilluspreparation, 3 g/day biolactis powder (BLP), in preventing colorectal tumor. The participants were provided an option to continue treatment with BLP on an outpatient basis after completion of the study. The 380 patients who completed the study were contacted and asked to participate in the present study and those who consented were surveyed for cancer incidence, treatment compliance, lifestyle, weight, and other variables. Informed consent was obtained from 237 of the 380 (62.4%) patients. The mean follow-up period was 7913 days (21.7 years). Cancer developed in 24 of 128 (18.8%) patients in the BLP extension group and 24 of 109 (22.0%) patients in the non-BLP extension group (risk ratio 0.88 [95% confidence interval 0.53-1.47]). Although no significant difference was observed, the cumulative cancer incidence rose at a slightly lower rate in the BLP extension group. Both groups showed a significant weight decrease over the course of 20 years, although the decrease in the BLP extension group was only 1.4 kg, compared with 2.8 kg in the non-BLP extension group. Very long-term treatment with aLactobacillusprobiotic preparation suppressed weight loss in the elderly.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid
    Watanabe, Toshio
    Nishio, Hikaru
    Tanigawa, Tetsuya
    Yamagami, Hirokazu
    Okazaki, Hirotoshi
    Watanabe, Kenji
    Tominaga, Kazunari
    Fujiwara, Yasuhiro
    Oshitani, Nobuhide
    Asahara, Takashi
    Nomoto, Koji
    Higuchi, Kazuhide
    Takeuchi, Koji
    Arakawa, Tetsuo
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 297 (03): : G506 - G513
  • [12] Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract:: Selective isolation from faeces and identification using monoclonal antibodies
    Yuki, N
    Watanabe, K
    Mike, A
    Tagami, Y
    Tanaka, R
    Ohwaki, M
    Morotomi, M
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1999, 48 (01) : 51 - 57
  • [13] Beneficial Effects of Long-Term Consumption of a Probiotic Combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult May Persist After Suspension of Therapy in Lactose-Intolerant Patients
    Almeida, Camila Casuccio
    Silva Lorena, Sonia Leticia
    Pavan, Celia Regina
    Imamura Akasaka, Helena Midori
    Mesquita, Maria Aparecida
    NUTRITION IN CLINICAL PRACTICE, 2012, 27 (02) : 247 - 251
  • [14] EFFECT OF ADMINISTRATION OF PROBIOTIC PREPARATION WITH STRAIN OF LACTOBACILLUS FERMENTUM ON THE WEIGHT GAIN OF THE YOUNG PIGEONS
    Malikova, Lenka
    Weis, Jan
    Hrncar, Cyril
    JOURNAL OF MICROBIOLOGY BIOTECHNOLOGY AND FOOD SCIENCES, 2013, 2 : 1469 - 1476
  • [15] Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models
    Takada, M.
    Nishida, K.
    Kataoka-Kato, A.
    Gondo, Y.
    Ishikawa, H.
    Suda, K.
    Kawai, M.
    Hoshi, R.
    Watanabe, O.
    Igarashi, T.
    Kuwano, Y.
    Miyazaki, K.
    Rokutan, K.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (07): : 1027 - 1036
  • [16] Probiotic strain Lactobacillus casei Shirota imprints a skin-homing profile on effector T-cells and exhibits dual mechanisms of immunoregulation
    Mann, E.
    Jialu, Y.
    Bernardo, D.
    Al-Hassi, H. Omar
    Hart, A.
    Thomas, L.
    Tee, C.
    Daulatzai, N.
    Landy, J.
    Peake, S.
    Yaqoob, P.
    Knight, S.
    IMMUNOLOGY, 2011, 135 : 194 - 194
  • [17] Restoration of the defective innate immune system following treatment with the probiotic lactobacillus casei shirota in patients with alcoholic cirrhosis: A proof of concept study
    Stadlbauer, Vanessa
    Mookerjee, Rajeshwar P.
    Hodges, Stephen
    Wright, Gavin A.
    Davies, Nathan
    Jalan, Rajiv
    HEPATOLOGY, 2007, 46 (04) : 864A - 865A
  • [18] Restoration of the defective innate immune system following treatment with the probiotic Lactobacillus casei Shirota in patients with alcoholic cirrhosis: A proof of concept study
    Stadlbauer, Vanessa
    Mookerjee, Rajeshwar
    Wright, Gavin
    Hodges, Stephen
    Jalan, Rajiv
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (15-16) : A44 - A44
  • [19] Restoration of the defective innate immune system following treatment with the probiotic Lactobacillus casei Shirota in patients with alcoholic cirrhosis:: a proof of concept study
    Stadlbauer, V.
    Mookerjee, R. P.
    Hodges, S. J.
    Wright, G. A. K.
    Davies, N. A.
    Jalan, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (1-2) : A10 - A10
  • [20] Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model
    Shida, K
    Takahashi, R
    Iwadate, E
    Takamizawa, K
    Yasui, H
    Sato, T
    Habu, S
    Hachimura, S
    Kaminogawa, S
    CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (04): : 563 - 570